HS Icon Blood, antisera, vaccines, toxins and cultures in  Flag Switzerland

2019
Exports | Imports
: $32.9B | $9.99B, World Rnk 1 / 201
Flag Rnk 3 / 1207 | World Rnk 5 / 222
Flag Rnk 5 / 1213

2018 - 2019
FASTEST GROWING MARKET | FASTEST GROWING ORIGIN
: $2.59B | $169M, United States |  Germany

2019
ECONOMIC COMPLEXITY of Switzerland
: 2.03, Rnk 2 / 147

2019
PRODUCT COMPLEXITY  IN Blood, antisera, vaccines, toxins and cultures
: 1.19, Rnk 110 / 1029

Exports In 2019, Switzerland exported $32.9B in Blood, antisera, vaccines, toxins and cultures, making it the 1st largest exporter of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 3rd most exported product in Switzerland. The main destination of Blood, antisera, vaccines, toxins and cultures exports from Switzerland are: United States ($9.13B), Germany ($4.76B), China ($2.06B), Belgium ($1.58B), and Canada ($1.56B).

The fastest growing export markets for Blood, antisera, vaccines, toxins and cultures of Switzerland between 2018 and 2019 were United States ($2.59B), Germany ($577M), and Russia ($264M).

Imports In 2019, Switzerland imported $9.99B in Blood, antisera, vaccines, toxins and cultures, becoming the 5th largest importer of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 5th most imported product in Switzerland. Switzerland imports Blood, antisera, vaccines, toxins and cultures primarily from: Ireland ($2.67B), Germany ($2.63B), United States ($2.42B), Japan ($412M), and Singapore ($389M).

The fastest growing import markets in Blood, antisera, vaccines, toxins and cultures for Switzerland between 2018 and 2019 were Germany ($169M), South Korea ($89.1M), and Austria ($65.9M).

Historical Data

#permalink to section
Value
Compare to

EXPORTS (2019): $32.9B

IMPORTS (2019): $9.99B

NET TRADE (2019): $22.9B

In 2019, Switzerland exported $32.9B in Blood, antisera, vaccines, toxins and cultures. The main destinations of Switzerland exports on Blood, antisera, vaccines, toxins and cultures were United States ($9.13B), Germany ($4.76B), China ($2.06B), Belgium ($1.58B), and Canada ($1.56B).

In 2019, Switzerland imported $9.99B in Blood, antisera, vaccines, toxins and cultures, mainly from Ireland ($2.67B), Germany ($2.63B), United States ($2.42B), Japan ($412M), and Singapore ($389M).

Explore Visualizations

IN 2019, Switzerland HAD A POSITIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:

IN 2019, Switzerland HAD A NEGATIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:

Flow

THE FASTEST GROWING Blood, antisera, vaccines, toxins and cultures EXPORT MARKETS FOR Switzerland WERE (2018 - 2019):

THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Blood, antisera, vaccines, toxins and cultures BY Switzerland WERE (2018 - 2019):

Explore Visualizations

Market Concentration

#permalink to section
Flow
Type

In 2019, Switzerland's main exporting competitors in Blood, antisera, vaccines, toxins and cultures were:

In 2019, Switzerland's main importing competitors in Blood, antisera, vaccines, toxins and cultures were:

Explore Visualizations

Tariffs by Country

#permalink to section

In 2018, the tariffs for Blood, antisera, vaccines, toxins and cultures in the imports of Switzerland were of 0% around the world.